CureSight | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

31 results for “CureSight”

Trials

View all 13 →

Treating Amblyopia With CureSight

20 participants · First posted Dec 11, 2023

CURESIGHT BINOCULAR AMBLYOPIA TREATMENT STUDY

23 participants · First posted Mar 8, 2021

Treatment for Amblyopia Under Binocular Conditions Versus the Standard of Care, Monocular Deprivation Treatment

114 participants · First posted Jan 11, 2022

Drugs

Gallium-68 NOTA AE105 (Curasight)

Gallium-68 NOTA AE105(Curasight A/S)

Organizations

Curasight A/S

Denmark

News

View all 15 →

Advancements in Ocular Therapies: Updates on Dry Eye, AMD, and Myopia Management

Curasight Prioritizes Brain Cancer for uTREAT Development Following Positive Q3 Report

Curasight Advances uTREAT Brain Cancer Therapy with Phase 1 Trial Submission to EMA

Page 1 of 4